DermaClip Receives Regulatory Approval in Panama, Opening Doors to International Expansion

Houston, TX – 07/18/2025. We’re proud to announce that DermaClip^® devices have officially received approval in Panama and have been issued the associated catalog numbers in the national medical directory, marking a significant milestone as we begin our expansion into Latin America. This approval allows DermaClip to be sold and distributed for clinical use across the Republic of Panama—bringing our non-invasive, needle-free wound closure system to a new population of patients and providers.

Partnering with Grupo Infinity

To support our launch and ongoing operations in Panama, we’ve partnered with Grupo Infinity, a trusted distributor with a strong track record in medical technologies across the region. Their extensive relationships with hospitals, clinics, and healthcare professionals will be instrumental in bringing DermaClip devices to the providers who need it most.

Grupo Infinity shares our mission of improving clinical care through innovative, easy-to-use solutions—and we’re excited to grow together in this important market.

A Better Way to Close Wounds—Now Available in Panama

The DermaClip device is a revolutionary skin closure device designed to close wounds quickly, without the need for needles, anesthetic, or complex training. Its unique design enables providers to:

• Close wounds in seconds
• Avoid puncturing fragile or sensitive skin
  
• Improve cosmetic outcomes by everting wound edges and eliminating “railroad track” scarring
• Streamline workflow with no need for follow-up appointments for removal

These features make DermaClip devices especially valuable in emergency medicine, urgent care, pediatric care, and resource-limited environments—sectors where time, training, and supplies can be stretched thin.

Why Panama?

Panama serves as both a key medical market and a strategic gateway to broader Latin American distribution. With a strong healthcare infrastructure, a growing private medical sector, and its central geographic location, Panama represents an ideal launch point for DermaClip’s international growth strategy.

What’s Next

With regulatory approval secured and Grupo Infinity onboard as our distribution partner, we are now preparing for:

• Initial sales and training with clinical partners
• Distributor onboarding and education
• Localized marketing and outreach to build awareness among healthcare providers

We’re excited to bring the benefits of DermaClip devices to new providers and patients—and this approval marks just the beginning.

Interested in bringing DermaClip to your region?

Contact our international team to learn more about partnership opportunities with DermaClip.

About DermaClip^®

DermaClip US, L.L.C. produces wound closure devices that are designed to optimize wound closure on patients, secure good healing results, make wound closure more efficient and less painful, and save time for all involved in the process. The Company’s patented devices have been used to close all types of wounds on all ages of patients, encompassing the full range from children to geriatrics. The devices have been used under all types of conditions, from treating injured warfighters in the field with the US Military, to the Emergency Room, the Urgent Care, the Operating Room and in doctor’s offices. You can see more about the devices at DermaClip.com and DermaQuik.com.

You can also find more about the DermaClip devices on Twitter, Facebook, LinkedIn, and Instagram.